The "Multi-Omic" Integration Layer
By 2026, "Genomics-only" informatics is considered obsolete. The standard of care has moved to Multi-Omic Informatics, where DNA sequencing is integrated with RNA-Seq (Transcriptomics), Proteomics, and Metabolomics.
The Unified Biological "Digital Twin": Platforms like Illumina Connected Multiomics now generate a "Digital Twin" of the patient. This model integrates somatic mutation data with protein expression levels to predict how a patient will respond to specific immunotherapies.
Computational Challenges: Analyzing these disparate datasets requires "Hyper-Scale Integration" tools. In 2026, high-performance computing (HPC) clusters utilize Graph Neural Networks (GNNs) to map the interactions between genes and proteins, identifying "pathway disruptions" that a single-ome analysis would miss. This has led to a 25% increase in the identification of actionable drug targets for "difficult-to-treat" solid tumors.